Assuntos
Tomada de Decisão Clínica/ética , Infecções por Coronavirus/epidemiologia , Transplante de Órgãos/ética , Seleção de Pacientes/ética , Pneumonia Viral/epidemiologia , Alocação de Recursos/ética , Aloenxertos/provisão & distribuição , Betacoronavirus/patogenicidade , COVID-19 , Infecções por Coronavirus/economia , Infecções por Coronavirus/prevenção & controle , Infecções por Coronavirus/transmissão , Efeitos Psicossociais da Doença , Humanos , Transplante de Órgãos/economia , Pandemias/economia , Pandemias/prevenção & controle , Pneumonia Viral/economia , Pneumonia Viral/prevenção & controle , Pneumonia Viral/transmissão , SARS-CoV-2 , Obtenção de Tecidos e Órgãos/economia , Obtenção de Tecidos e Órgãos/ética , Obtenção de Tecidos e Órgãos/organização & administraçãoRESUMO
Organ transplantation as an option to overcome end-stage diseases is common in countries with advanced healthcare systems and is increasingly provided in emerging and developing countries. A review of the literature points to sex- and gender-based inequity in the field with differences reported at each step of the transplant process, including access to a transplantation waiting list, access to transplantation once waitlisted, as well as outcome after transplantation. In this review, we summarize the data regarding sex- and gender-based disparity in adult and pediatric kidney, liver, lung, heart, and hematopoietic stem cell transplantation and argue that there are not only biological but also psychological and socioeconomic issues that contribute to disparity in the outcome, as well as an inequitable access to transplantation for women and girls. Because the demand for organs has always exceeded the supply, the transplant community has long recognized the need to ensure equity and efficiency of the organ allocation system. In the spirit of equity and equality, the authors call for recognition of these inequities and the development of policies that have the potential to ensure that girls and women have equitable access to transplantation.
Assuntos
Identidade de Gênero , Disparidades nos Níveis de Saúde , Disparidades em Assistência à Saúde , Transplante de Órgãos , Caracteres Sexuais , Doadores de Tecidos/provisão & distribuição , Seleção do Doador , Feminino , Sobrevivência de Enxerto , Humanos , Masculino , Transplante de Órgãos/efeitos adversos , Complicações Pós-Operatórias/etiologia , Medição de Risco , Fatores de Risco , Fatores Sexuais , Resultado do Tratamento , Listas de EsperaRESUMO
A consensus conference on frailty in kidney, liver, heart, and lung transplantation sponsored by the American Society of Transplantation (AST) and endorsed by the American Society of Nephrology (ASN), the American Society of Transplant Surgeons (ASTS), and the Canadian Society of Transplantation (CST) took place on February 11, 2018 in Phoenix, Arizona. Input from the transplant community through scheduled conference calls enabled wide discussion of current concepts in frailty, exploration of best practices for frailty risk assessment of transplant candidates and for management after transplant, and development of ideas for future research. A current understanding of frailty was compiled by each of the solid organ groups and is presented in this paper. Frailty is a common entity in patients with end-stage organ disease who are awaiting organ transplantation, and affects mortality on the waitlist and in the posttransplant period. The optimal methods by which frailty should be measured in each organ group are yet to be determined, but studies are underway. Interventions to reverse frailty vary among organ groups and appear promising. This conference achieved its intent to highlight the importance of frailty in organ transplantation and to plant the seeds for further discussion and research in this field.
Assuntos
Fragilidade , Transplante de Órgãos , Sociedades Médicas , Alocação de Recursos para a Atenção à Saúde , Humanos , Estados UnidosAssuntos
Doadores Vivos , Transplante de Órgãos , Coleta de Tecidos e Órgãos , Altruísmo , Doações , Custos de Cuidados de Saúde , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Doadores Vivos/psicologia , Motivação , Transplante de Órgãos/efeitos adversos , Transplante de Órgãos/economia , Transplante de Órgãos/métodos , Medição de Risco , Fatores de Risco , Fatores de Tempo , Coleta de Tecidos e Órgãos/efeitos adversos , Coleta de Tecidos e Órgãos/economia , Coleta de Tecidos e Órgãos/métodos , Resultado do TratamentoRESUMO
BACKGROUND: Although residential segregation has been implicated in various negative health outcomes, its association with kidney transplantation has not been examined. METHODS: Age- and sex-standardized kidney transplantation rates were calculated from the Scientific Registry of Transplant Recipients, 2000-2013. Population characteristics including segregation indices were derived from the 2010 U.S. Census data and the U.S. Renal Data System. Separate multivariable Poisson regression models were constructed to identify factors independently associated with kidney transplantation among Blacks and Whites. RESULTS: Median age- and sex-standardized kidney transplantation rates were 114 per 100,000 for Blacks and 38 per 100,000 for Whites. 16.1% of the U.S. population lived in counties with high segregation. There was no difference in the kidney transplantation rates across the levels of segregation among Blacks and Whites. CONCLUSION: Factors other than residential segregation may play roles in kidney transplantation disparities. Continued efforts to identify these factors may be beneficial in reducing transplantation disparities across the U.S. SUMMARY: Using the Scientific Registry of Transplant Recipients and U.S. census data, we aimed to determine whether residential segregation was associated with kidney transplantation rates. We found that there was no association between residential segregation and kidney transplantation rates.
Assuntos
Negro ou Afro-Americano/estatística & dados numéricos , Transplante de Rim/estatística & dados numéricos , Características de Residência/estatística & dados numéricos , População Branca/estatística & dados numéricos , Censos , Humanos , Sistema de Registros , Estados Unidos/epidemiologiaRESUMO
Success of renal transplantation, as a viable alternative to dialysis, has been tempered by long-standing racial disparities. Ethnic minorities have less access to transplantation, are less likely to be listed for transplantation, and experience a higher rate of graft failure. Reasons for the existing racial disparities at various stages of the transplantation process are complex and multi-factorial. They include a combination of behavioral, social, environmental, and occupational factors, as well as potential intended or unintended discrimination within the healthcare system. Immunologic factors such as human leukocyte antigen matching, composition of the organ donor pool, and patient immune response, all of which affect post-transplantation graft rejection rates and patient survival, also contribute to health disparities between ethnic groups.